SCIENCE
EBV: The Silent Traveler in Your Body
Tue May 20 2025
The Epstein-Barr virus (EBV) is a sneaky invader. It enters the body through the throat, but it does not stay there. Instead, it travels to different parts of the body, like the gut and the brain. This journey can lead to serious problems, including cancer and autoimmune disorders.
Scientists have been studying how EBV moves around the body. They found that the virus changes B cells, a type of white blood cell. These changed B cells start to move around more, like they are looking for a new home. This movement is guided by signals in the body, specifically a substance called CCL4 and a receptor called CCR1. If CCR1 is not present, the B cells do not move or grow as much.
The moving B cells also have another trick. They can squeeze through the walls of blood vessels, a process known as diapedesis. This is made possible by another signal, ICAM-1, which the B cells induce on the blood vessel walls. This squeezing action can damage the blood vessel walls, making them less effective at keeping things out.
All of this movement and squeezing is controlled by a protein called FAK. When FAK is blocked, the B cells cannot grow, survive, or spread to other parts of the body, like the spleen and brain. This is important because it shows that stopping the movement of these B cells could be a way to reduce the harm caused by EBV.
But there is more to the story. The infected B cells also release a substance called IL-10. This substance attracts other B cells that do not have EBV but have been linked to autoimmune disorders. These B cells also move and squeeze through blood vessel walls, adding to the chaos.
So, what does all of this mean? It means that EBV is not just a simple virus. It changes B cells, making them move and squeeze through blood vessel walls. This can lead to serious health problems. But it also means that there might be ways to stop this movement and reduce the harm caused by EBV. This is an important area of research, as it could lead to new treatments for the diseases caused by this sneaky invader.
continue reading...
questions
Is it possible that pharmaceutical companies are suppressing information about EBV to keep selling ineffective treatments?
How does the Epstein-Barr virus specifically target distant organs like the gut and the brain after initial infection in the pharynx?
What are the precise mechanisms by which EBV-infected B cells induce ICAM-1 on endothelial cells and disrupt barrier integrity?
inspired by
actions
flag content